77 related articles for article (PubMed ID: 21368605)
1. Tumoricidal effect of strontium-89.
Yoshimura M; Saito K; Park J; Akata S; Koizumi K; Tokuue K; Kakizaki D
Clin Nucl Med; 2011 Apr; 36(4):296-9. PubMed ID: 21368605
[No Abstract] [Full Text] [Related]
2. [89-Strontium for painful osteoblastic metastases].
Golan H; Ratz D
Harefuah; 1995 May; 128(10):650-4. PubMed ID: 7541384
[No Abstract] [Full Text] [Related]
3. [Internal strontium-89 radiotherapy for malignant bony metastasis].
Lou C; Zhang D; Yu L
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):507-9. PubMed ID: 11859724
[TBL] [Abstract][Full Text] [Related]
4. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
Flamm J; Burkert S
Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
[TBL] [Abstract][Full Text] [Related]
5. Radioactive strontium-89 for painful bone metastases.
Med Lett Drugs Ther; 1993 Oct; 35(908):102. PubMed ID: 7692227
[No Abstract] [Full Text] [Related]
6. Complete regression of multiple painful bone metastases from hepatocellular carcinoma after administration of strontium-89 chloride.
Suzawa N; Yamakado K; Takaki H; Nakatsuka A; Takeda K
Ann Nucl Med; 2010 Oct; 24(8):617-20. PubMed ID: 20490724
[TBL] [Abstract][Full Text] [Related]
7. The clinic presentation of hepatocellular carcinoma by bone secondaries: a report of 25 cases.
Alavi AH
Ethiop Med J; 1986 Jan; 24(1):71-3. PubMed ID: 3002785
[No Abstract] [Full Text] [Related]
8. Strontium 89 in the treatment of bony metastases.
Porter AT; Ben-Josef E
Important Adv Oncol; 1995; ():87-94. PubMed ID: 7545646
[No Abstract] [Full Text] [Related]
9. Strontium-89 for the palliation of bone pain due to metastatic disease.
Taylor AJ
J Nucl Med; 1994 Dec; 35(12):2054. PubMed ID: 7527458
[No Abstract] [Full Text] [Related]
10. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
Ouyang W; Liu JH; Liu WY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
[TBL] [Abstract][Full Text] [Related]
11. The Sr-89 bracelet.
Amdur R; Eaton W; Mitchell S; Leopold K; Filimonov A
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):897. PubMed ID: 7790282
[No Abstract] [Full Text] [Related]
12. [Costal metastases as the initial manifestation of a hepatocellular carcinoma].
Atienza García A; Cremades Romero MJ; Lacruz Rodrigo J; Calabuig Alborch J
Rev Clin Esp; 1990 Jun; 187(1):38-9. PubMed ID: 2176728
[No Abstract] [Full Text] [Related]
13. Systemic radionuclide therapy of bone metastases with strontium-89.
Porter AT; Davis LP
Oncology (Williston Park); 1994 Feb; 8(2):93-6; discussion 96, 99-101. PubMed ID: 8167090
[TBL] [Abstract][Full Text] [Related]
14. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.
Hansen DV; Holmes ER; Catton G; Thorne DA; Chadwick DH; Schmutz DA
Am Fam Physician; 1993 Jun; 47(8):1795-800. PubMed ID: 7684554
[TBL] [Abstract][Full Text] [Related]
15. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma.
Breen SL; Powe JE; Porter AT
J Nucl Med; 1992 Jul; 33(7):1316-23. PubMed ID: 1613572
[TBL] [Abstract][Full Text] [Related]
16. [Strontium-89 for bone metastases from prostate cancer: an update].
Zhao WW; Xie P; Deng HF
Zhonghua Nan Ke Xue; 2010 Mar; 16(3):269-72. PubMed ID: 20369560
[TBL] [Abstract][Full Text] [Related]
17. Hypocalcemia associated with strontium-89 administration in a patient with diffuse bone metastases from neuroendocrine carcinoma.
Mori M; Fadul NA; Bruera E; Dalal S
J Pain Symptom Manage; 2009 May; 37(5):923-9. PubMed ID: 19041217
[TBL] [Abstract][Full Text] [Related]
18. Autopsy of a cadaver containing strontium-89-chloride.
Schraml FV; Parr LF; Ghurani S; Silverman ED
J Nucl Med; 1997 Mar; 38(3):380-2. PubMed ID: 9074523
[TBL] [Abstract][Full Text] [Related]
19. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.
Bolger JJ; Dearnaley DP; Kirk D; Lewington VJ; Mason MD; Quilty PM; Reed NS; Russell JM; Yardley J
Semin Oncol; 1993 Jun; 20(3 Suppl 2):32-3. PubMed ID: 7684863
[No Abstract] [Full Text] [Related]
20. [2 years of experience with 89Sr therapy of multiple bone metastases (author's transl)].
Correns HJ; Mitterlechner E; Buchali K; Schnorr D; Seidel C; Mebel M
Radiobiol Radiother (Berl); 1979 Jun; 20(3):360-2. PubMed ID: 515396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
